Cardiothoracic Surgery
MD, PhD, President, Shanghai Pulmonary Hospital; Director, Shanghai Engineering Research Center of Lung Transplantation, China
MD, PhD. Director of Shanghai Engineering Research Center of Lung Transplantation. Secretary of the party committee of Shanghai Pulmonary Hospital, Shanghai, China
Selected publications from PubMed
Predicting recurrence within 5 years in Early-Stage lung adenocarcinoma with micropapillary and solid patterns.
Wang Z, Chen J, Xu Y, Lin T, Chen C, Shen Y, Huang J, Xu S, Chen S
Int J Med Inform. 2026 Sep 15;218:106542 doi: 10.1016/j.ijmedinf.2026.106542.
A novel rat model for group 2 pulmonary hypertension by total pulmonary vein banding: Multi-omics insights into pathophysiological mechanisms.
Shentu J, Dai W, Chen C, Huang J, Chen L, Yan Y, Zhang H, Zhu Z, Shi G, Chen H
J Thorac Cardiovasc Surg. 2026 Aug;172(2):349-360.e14 doi: 10.1016/j.jtcvs.2026.01.017.
Machine learning models predict survival in unresectable stage III non-small cell lung cancer: Surveillance, Epidemiology, and End Results and Chinese cohort study.
Zhang Y, Hu S, Wang J, Wu Z, Chen C, Chen W, Xie L
J Thorac Dis. 2026 Jul 31;18(7):710 doi: 10.21037/jtd-2026-1063.
Predicting Anastomotic Leak After Neoadjuvant Chemoimmunotherapy and Esophagectomy: A Dynamic Inflammatory and Nutritional Biomarker Model.
Yang Z, Huang Y, Chen M, Cai B, Li H, Zeng T, Zhang S, Chen C, Zheng B
J Inflamm Res. 2026;19:614162 doi: 10.2147/JIR.S614162.
Survival differences among patients with nonpathological complete response with distinct pathological outcomes after neoadjuvant therapy for esophageal squamous cell carcinoma.
Chen H, Chen C, Lv H, Zhao J, Lin J, Wang C, Shen J, Mei X, Han Y, Wang Q, Lv J, Yan X, Liu Z, Zhang Z, Zhong Q, Jiang Y, Xu L, Li X, Qian D, Ma D, Ye M, Wang C, Wang Z, Tian Z, Li Z, Guo X, Leng X
J Thorac Cardiovasc Surg. 2026 Jul 29 pii: S0022-5223(26)01163-3. doi: 10.1016/j.jtcvs.2026.07.013.
Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we are proud to introduce Meet the Masters, as part of the Healing in China series, which brings together the best Chinese KOLs and top surgeons from other regions of the world to guide you through their surgeries and transfer years of knowledge. In this event, AIS Channel specially invites top thoracic surgery experts from China and the United States to share academic insights on segmentectomy. This event features operation videos, case sharing, and interactive discussions to enhance surgical skills and improve global standards in this field.
With Johnson & Johnson MedTech
Published
Jan 2024
Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we proudly introduce Meet the Institutions, as part of the Healing in China series, which gives you access to the best centers of excellence in China, and the opportunity to collaborate with these hospitals and participate in activities and projects organized by them.
With Johnson & Johnson MedTech
Published
Oct 2023
Welcome and Introduction - Dr. Ke En Oh (Ireland) Case Introduction - Dr. Kunpeng Zhang (China) Surgical Procedure by Phases: Bronchoplasty in Right Upper Lobectomy after neoadjuvant targeted therapy - Performed by Dr. Chang Chen (China) Discussion and closing remarks - All faculty moderated by Dr. Ke En Oh (Ireland)
With Johnson & Johnson MedTech
Published
Nov 2022
Help your network discover Dr. Chang Chen's clinical expertise.
